MARKET

MRNA

MRNA

Moderna
NASDAQ
223.37
-7.98
-3.45%
After Hours: 218.00 -5.37 -2.40% 19:59 11/13 EST
OPEN
224.90
PREV CLOSE
231.35
HIGH
231.35
LOW
221.70
VOLUME
8.09M
TURNOVER
--
52 WEEK HIGH
280.80
52 WEEK LOW
22.28
MARKET CAP
90.38B
P/E (TTM)
-31.4818
1D
5D
1M
3M
1Y
5Y
1D
Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027?
The Motley Fool · 1d ago
What Moved Markets This Week
Seeking Alpha · 1d ago
Nasdaq gains 2% in a bumpy week for Wall Street; Nvidia loses ~13%
Seeking Alpha · 2d ago
Moderna Chief Legal Officer Announces Retirement Agreement
TipRanks · 2d ago
Moderna Inc. Stock Slips 3.4%, Underperforms Peers
Dow Jones · 2d ago
Evercore ISI Keeps Their Hold Rating on Moderna (MRNA)
TipRanks · 2d ago
Moderna (MRNA) Lands New Vaccine Data Win And Global Index Inclusion
Simply Wall St · 2d ago
Notable Friday Option Activity: IREN, ADBE, MRNA
NASDAQ · 2d ago
More
About MRNA
Moderna, Inc. is a biotechnology company advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is engaged in developing medicines across infectious disease vaccines, oncology therapeutics and rare disease therapeutics. Its platform incorporates advances across three components, mRNA, delivery, and the manufacturing process, to advance its medicines. Its products are Spikevax and mNEXSPIKE (its COVID vaccines), and mRESVIA (its vaccine against respiratory syncytial virus (RSV)). It also has a diverse development pipeline that consists of 35 therapeutic and vaccine programs, six of which are in late-stage development. It has regulatory filings under review for its seasonal flu+COVID vaccine (mRNA-1083) in Europe and Canada and for its seasonal flu vaccine (mRNA-1010) in the United States, Europe, Canada and Australia. Its rare disease programs are Propionic acidemia (mRNA-3927); Methylmalonic acidemia (mRNA-3705), and Cystic Fibrosis (mRNA-3692/VX-522).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.